InvestorsHub Logo
icon url

DaubersUP

11/03/17 8:08 AM

#202381 RE: scottsmith #202378

Here is my faith! Pre clinical work:

http://slideplayer.com/slide/219787/1/images/14/Prurisol+for+Psoriasis.jpg

And then the fact the phase 2a produced results in the 200mg arm of achieving the primary endpoint of showing a GREATER THAN OR EQUAL TO a 2 point reduction using the IGA scale in 35% of patients.

And the percentage was greater if you filtered only MODERATE (IGA 3) patients. I think it was 46% or something. Moving from 3 to 1 or 0 is considered higher than a PASI 75. And the trial proved a dose dependency. So I'm expecting 300 and 400 to show even better data.

But again. Let's see the data early next year.